Gossamer Bio

NEWS

Business

Two Former Receptos Execs Launch New San Diego Biotech Startup With $100M

It is not clear what the new company’s focus is just yet.

January 4, 2018

·

2 min read

·

AWARDS

JOBS

IN THE PRESS

Press Releases

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 9, 2025

December 10, 2025

·

1 min read

Press Releases

Gossamer Bio to Participate in Upcoming December 2025 Investor Conferences

November 25, 2025

·

1 min read

Press Releases

Gossamer Bio to Participate in Upcoming November 2025 Investor Conferences

November 10, 2025

·

1 min read

Press Releases

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 7, 2025

November 10, 2025

·

1 min read

Press Releases

Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update

November 5, 2025

·

10 min read

Press Releases

Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital

September 26, 2025

·

4 min read

Press Releases

Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension

September 26, 2025

·

7 min read

Press Releases

Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025

September 23, 2025

·

2 min read

Press Releases

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 10, 2025

September 10, 2025

·

1 min read

Press Releases

Gossamer Bio to Present at Upcoming September 2025 Investor Conferences

September 1, 2025

·

1 min read